Response to Milland et al.: Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies.
Zhou
Dapeng
D
Levery
Steven B
SB
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000918:Antibody Specificity; D016466:CHO Cells; D002241:Carbohydrates / Q000276:immunology*; D006224:Cricetinae; D003412:Cricetulus; D004187:Disaccharides / Q000276:immunology*; D000939:Epitopes / Q000276:immunology; D005700:Galactosyltransferases / Q000235:genetics / Q000378:metabolism*; D006028:Glycosphingolipids / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D051381:Rats; D014162:Transfection
D000911:Antibodies, Monoclonal; D002241:Carbohydrates; D004187:Disaccharides; D000939:Epitopes; D006028:Glycosphingolipids; C055075:galactosyl-(1-3)galactose; D005700:Galactosyltransferases; C413211:UDP-galactose beta-D-galactosyl-1,4-glycosylceramide alpha-1,3-galactosyltransferase